NorthCoast Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$953K Hold
12,688
0.03% 271
2021
Q2
$987K Sell
12,688
-339
-3% -$25.2K 0.04% 266
2021
Q1
$959K Buy
13,027
+1,125
+9% +$83K 0.04% 237
2020
Q4
$929K Sell
11,902
-18,693
-61% -$1.43M 0.04% 215
2020
Q3
$2.42M Sell
30,595
-41,263
-57% -$3.23M 0.12% 115
2020
Q2
$5.3M Sell
71,858
-29,167
-29% -$2.2M 0.3% 67
2020
Q1
$7.42M Buy
+101,025
New +$7.94M 0.48% 59
2019
Q3
Sell
-59,495
Closed -$4.76M 258
2019
Q2
$4.76M Sell
59,495
-1,398
-2% -$107K 0.31% 68
2019
Q1
$4.83M Buy
60,893
+3,616
+6% +$270K 0.32% 66
2018
Q4
$4.18M Buy
+57,277
New +$4.04M 0.32% 63
2015
Q4
Sell
-89,136
Closed -$4.2M 174
2015
Q3
$4.2M Sell
89,136
-46,686
-34% -$2.48M 0.23% 55
2015
Q2
$7.38M Sell
135,822
-5,342
-4% -$300K 0.35% 40
2015
Q1
$7.74M Buy
141,164
+21,023
+17% +$1.19M 0.36% 38
2014
Q4
$6.51M Buy
120,141
+99,682
+487% +$5.55M 0.32% 37
2014
Q3
$1.16M Hold
20,459
0.06% 111
2014
Q2
$1.13M Buy
+20,459
New +$1.12M 0.07% 108

Other funds holding MRK

NorthCoast Asset Management's MRK Position: Q3 2021 in Review

NorthCoast Asset Management held its Merck (MRK) position steady in Q3 2021 at 12,688 shares worth $953K. The position accounts for 0.03% of the portfolio, ranked #271.

NorthCoast Asset Management first reported a position in MRK in Q2 2014 and has held it in 16 quarters since. The position peaked at $7.74M in Q1 2015. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • NorthCoast Asset Management held 12,688 shares of Merck worth $953K as of Q3 2021.
  • NorthCoast Asset Management left its Merck share count unchanged in Q3 2021.
  • Merck made up 0.03% of NorthCoast Asset Management's portfolio in Q3 2021, its #271 holding.
  • NorthCoast Asset Management first reported a position in Merck in Q2 2014 and has held it in 16 quarters since.
  • NorthCoast Asset Management's Merck position peaked at $7.74M in Q1 2015.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.